Sign inJoin waitlistJoin the waitlist

William Symmans

Director, Research Operations · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Cytopathology
University of Texas M D Anderson Cancer Center
1992–1993
Pathology
New York Presbyterian Hospital
1991–1992
Waikato Public Hospital
1986–1988
Doctor of Medicine
1983–1987
Bates College

Research

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Annals of Oncology · 2015 · 2,547 citations
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Journal of Clinical Oncology · 2008 · 2,356 citations
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
Clinical Cancer Research · 2005 · 1,418 citations

Lajos Pusztai
144 papers
Gabriel Hortobagyi
90 papers
Vicente Valero
51 papers
Laura Esserman
41 papers
Angela DeMichele
38 papers
Henry Kuerer
37 papers · 1 as a resident
SM
Stacy Moulder
34 papers
Hope Rugo
33 papers
Judy Boughey
32 papers · 9 as a resident
Douglas Yee
31 papers
Kelly Hunt
29 papers
Claudine Isaacs
26 papers

Grants

Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to Predict Benefit from Extended Duration of Adjuvant Endocrine Therapy in the NSABP B-42 Trial
National Cancer Institute · UH3
Contact PI · $721.5K · University of Tx Md Anderson Can Ctr
2023–2026
Integrating Biospecimen Science Into The Development Of RNA-Based Clinical Assays For Patients With Metastatic Breast Cancer
National Cancer Institute · U01
Contact PI · $1.6M · University of Tx Md Anderson Can Ctr
2017–2023
ER Reporter Genes To Predict Response To Endocrine Therapy
National Cancer Institute · R21
Contact PI · $307.9K · University of Tx Md Anderson Can Ctr
2006–2009